Multi-Omics Integration Reveals That SN-011 Targets JUNB to Upregulate ADGRE5 and Restore Vascular Endothelial Cell Communication in Ischemic Stroke.

Overview

1. The Affiliated Xuzhou Rehabilitation Hospital of Xuzhou Medical University Xuzhou Jiangsu Province China

Abstract

Ischemic stroke (IS) is a cerebrovascular disease with high mortality and disability rates, currently lacking effective therapeutic targets. The STING inhibitor SN‐011 shows potential in IS treatment, but its mechanism of action remains unclear. This study aims to explore the key molecular mechanisms of SN‐011 in treating IS through bioinformatics approaches. IS transcriptome datasets were analyzed to identify differentially expressed genes. Mendelian randomization using brain eQTL and IS‐GWAS data identified genes with causal relationships to IS. Single‐cell transcriptome, pseudo‐time trajectory, intercellular communication, and transcription factor regulatory network analyzes were performed. Molecular docking and DARTS‐WB assay validated SN‐011 binding to transcription factors. Transcriptomic analysis identified 77 intersecting genes. Mendelian randomization revealed ADGRE5 as a protective gene for IS (OR < 1), significantly downregulated in venous endothelial cells (vECs) during disease progression. Cell communication analysis showed ADGRE5‐high vECs interact with immune, glial, and stromal cells via LAMININ (Lamb2‐CD44, Lamb2‐Itga6+Itgb1, Lamb2‐Dag1 pair) and JAM signaling pathways. Transcription factor analysis identified JUNB as a negative regulator of ADGRE5. Molecular docking (−6.8 kcal/mol) combined with an in vitro DARTS‐WB assay confirmed the interaction between SN‐011 and JUNB. In OGD‐induced endothelial cell injury models, SN‐011 suppressed JUNB expression, restored ADGRE5 expression inhibited by JUNB overexpression, reversed the downregulation of LAMB2 and CD44, and reduced the expression of the pro‐inflammatory cytokines IL‐6 and IL‐1β. Notably, blockade of LAMB2 largely abolished these protective effects, indicating that the anti‐inflammatory and endothelial‐protective activities of SN‐011 are mediated, at least in part, through restoration of the LAMB2‐CD44 signaling axis. ADGRE5 downregulation in vECs may impair vascular repair by disrupting LAMININ‐mediated intercellular communication. SN‐011 may exert neuroprotective effects by targeting JUNB to upregulate ADGRE5 expression and restore the vEC‐centered cellular communication network, providing a theoretical basis for SN‐011 as a potential IS therapeutic.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Data links

• ncbi.nlm.nih.gov/geo/browse — NCBI; found in the text, “Data Acquisition”

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 3, 28 September 2026

• Publisher: — → Wiley

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 2 authors, 4 keywords, 11 MeSH terms, 58 references.

Cite

This paper

Ou, X., & Gong, Z. (2026). Multi-Omics Integration Reveals That SN-011 Targets JUNB to Upregulate ADGRE5 and Restore Vascular Endothelial Cell Communication in Ischemic Stroke. Chemical biology & drug design, 108(2), e70363. https://doi.org/10.1111/cbdd.70363

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1097/md.0000000000048634

Identifying therapeutic target genes for stroke through systematic druggable Mendelian randomization analysis.

Journal: Medicine

In common: stroke, genetics / omics, cellular / molecular, 1 reference

[2] doi:10.1161/jaha.125.046208

Integration of Genome-Wide Association Studies With Single-Cell and Bulk Expression Quantitative Trait Locus to Identify Stroke Susceptibility Genes.

Journal: Journal of the American Heart Association

In common: stroke, genetics / omics, cellular / molecular, 1 reference

[3] doi:10.1002/alz.71433

Genetic correlation analysis of Alzheimer's disease and stroke implicates PHLPP1 as a shared locus in individuals of African ancestry.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

In common: stroke, genetics / omics, cellular / molecular, 1 reference

[4] doi:10.1093/braincomms/fcag322 [code]

Genomic insights into stroke recovery: cross-phenotype associations.

Journal: Brain communications

In common: stroke, genetics / omics, 1 reference

[5] doi:10.1177/0271678x261471282 [code]

Single-cell analysis of microglia and monocyte dynamics uncovers distinct TNF-driven neuroimmune signatures in humans after intracerebral hemorrhage.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

In common: stroke, cellular / molecular, 1 reference

[6] doi:10.64898/2026.08.12.26360241

Diffusion kurtosis imaging (gen)omics unravels mechanisms of cerebral small vessel disease

Journal: medRxiv (preprint)

In common: stroke, genetics / omics, cellular / molecular, 1 reference

[7] doi:10.3389/ebm.2026.10948

Genetic evidence for causal relationships between brain functional networks and domain-specific recovery after nondisabling ischemic stroke.

Journal: Experimental biology and medicine (Maywood, N.J.)

In common: stroke, genetics / omics, 1 reference

[8] doi:10.1161/jaha.125.046088 [code]

Systematic Identification of Therapeutic Targets and Repurposed Drugs for Stroke: From Genome Causal Analysis to Multilevel Validation.

Journal: Journal of the American Heart Association

In common: stroke, genetics / omics, 1 reference

[9] doi:10.1007/s10565-026-10177-0

Multi-omics analysis and experimental validation reveal the IRF7-CXCL10 axis as a master regulator of microglial PCD in ischemic stroke.

Journal: Cell biology and toxicology

In common: stroke, genetics / omics, cellular / molecular, 1 reference

[10] doi:10.1038/s43587-026-01204-0

Fibronectin mediates APOE4-driven blood-brain barrier dysfunction in Alzheimer's disease.

Journal: Nature aging

In common: genetics / omics, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.